cupravit 35 wg
bayer ag - rame ossicloruro; - microgranuli idrodispersibili - 35.0 g i valori indicati sono per 100 g di prodotto. - rame; metallo; da; ossicloruro; 35% - fungicida
sodio cloruro 0,9% galenica senese
industria farmaceutica galenica senese - acqua per preparazioni iniettabili, sodio cloruro - sodio cloruro - 9 milligrammo (i); acqua per preparazioni iniettabili - nd, acqua per preparazioni iniettabili - nd ; sodio cloruro - 9 grammo (i), sodio cloruro - 9 grammo (i) ; acqua per preparazioni iniettabili - 1000 millilitro (i), acqua per preparazioni iniettabili - nd ; sodio cloruro - 9 mg, acqua per preparazioni iniettabili - 1000 ml; sodio cloruro - 9 g, sodio cloruro - 9 g; acqua per preparazioni iniettabili - nd, sodio cloruro - 9 g; acqua per preparazioni iniettabili - 1000 ml - electrolytes
sodio cloruro 0,9% - soluzione fisiologica
s.a.l.f. s.p.a. laboratorio farmacologico - sodio cloruro - sodio cloruro - 9 grammo (i), sodio cloruro - 9 g - electrolytes
sodio cloruro 0,9% piramal.-revocato
piramal critical care italia s.p.a. - sodio cloruro - sodio cloruro - 9 g - electrolytes
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabete mellito, tipo 2 - farmaci usati nel diabete - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 per i dati disponibili su diverse combinazioni).
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
ossicloruro 50
isagro copper s.r.l. - rame ossicloruro; - polvere bagnabile - 50.0 g i valori indicati sono per 100 g di prodotto.
ossicloruro di rame 2 solplant
solplant s.p.a. - rame ossicloruro; olio di paraffina/(cas 8012-95-1); - concentrato emulsionabile - 17.0 g; 60.0 g i valori indicati sono per 100 g di prodotto.
ossicloruro di rame solplant
syngenta italia s.p.a. - rame ossicloruro; - polvere bagnabile - 50.0 g i valori indicati sono per 100 g di prodotto.